99 related articles for article (PubMed ID: 3992882)
1. Thioridazine toxicity--an experimental cardiovascular study of thioridazine and its major metabolites in overdose.
Heath A; Svensson C; Mårtensson E
Vet Hum Toxicol; 1985 Apr; 27(2):100-5. PubMed ID: 3992882
[TBL] [Abstract][Full Text] [Related]
2. Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans.
Hartigan-Go K; Bateman DN; Nyberg G; Mårtensson E; Thomas SH
Clin Pharmacol Ther; 1996 Nov; 60(5):543-53. PubMed ID: 8941027
[TBL] [Abstract][Full Text] [Related]
3. The effects of thioridazine on electrical and ischemic ventricular fibrillation in the dog heart in situ.
Davis JC; Bigger JT
J Pharmacol Exp Ther; 1981 Jan; 216(1):39-44. PubMed ID: 7452506
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity of thioridazine and two stereoisomeric forms of thioridazine 5-sulfoxide in the isolated perfused rat heart.
Hale PW; Poklis A
Toxicol Appl Pharmacol; 1986 Oct; 86(1):44-55. PubMed ID: 3764935
[TBL] [Abstract][Full Text] [Related]
5. Thioridazine-5-sulfoxide cardiotoxicity in the isolated, perfused rat heart.
Hale PW; Poklis A
Toxicol Lett; 1984 Apr; 21(1):1-8. PubMed ID: 6719481
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
[TBL] [Abstract][Full Text] [Related]
7. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose.
Buckley NA; Chevalier S; Leditschke IA; O'Connell DL; Leitch J; Pond SM
Crit Care; 2003 Oct; 7(5):R101-7. PubMed ID: 12974977
[TBL] [Abstract][Full Text] [Related]
8. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.
Eap CB; Souche A; Koeb L; Baumann P
Ther Drug Monit; 1991 Jul; 13(4):356-62. PubMed ID: 1780970
[TBL] [Abstract][Full Text] [Related]
9. Absorption and excretion of thioridazine and mesoridazine in man.
Charalampous KD; Johnson PC; Estevez V
Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456
[TBL] [Abstract][Full Text] [Related]
10. The biotransformation of thioridazine to thioridazine 5-sulfoxide stereoisomers in phenobarbital induced rats.
Hale PW; Poklis A
Eur J Drug Metab Pharmacokinet; 1986; 11(4):283-9. PubMed ID: 3582423
[TBL] [Abstract][Full Text] [Related]
11. Acute overdosage with thioridazine: a review of the available clinical exposure.
Le Blaye I; Donatini B; Hall M; Krupp P
Vet Hum Toxicol; 1993 Apr; 35(2):147-50. PubMed ID: 8470359
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of thioridazine and thioridazine metabolites in erythrocytes.
Svensson C; Nyberg G; Axelsson R; Mårtensson E
Psychopharmacology (Berl); 1986; 89(3):291-2. PubMed ID: 3088651
[TBL] [Abstract][Full Text] [Related]
13. Degradation and configurational changes of thioridazine 2-sulfoxide.
de Gaitani CM; Martinez AS; Bonato PS
J Pharm Biomed Anal; 2004 Nov; 36(3):601-7. PubMed ID: 15522536
[TBL] [Abstract][Full Text] [Related]
14. Bupivacaine cardiovascular toxicity: comparison of treatment with bretylium and lidocaine.
Kasten GW; Martin ST
Anesth Analg; 1985 Sep; 64(9):911-6. PubMed ID: 4025854
[TBL] [Abstract][Full Text] [Related]
15. Thioridazine 5-sulfoxide diastereoisomers in serum and urine from rats and man after chronic thioridazine administration.
Hale PW; Poklis A
J Anal Toxicol; 1985; 9(5):197-201. PubMed ID: 4057956
[TBL] [Abstract][Full Text] [Related]
16. Electrocardiographic changes following intravenous administration of thioridazine to macaque monkeys.
Moore RH; Rainey JM
J Clin Psychiatry; 1982 May; 43(5 Pt 2):41-3. PubMed ID: 7076640
[TBL] [Abstract][Full Text] [Related]
17. Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine.
Kilts CD; Knight DL; Mailman RB; Widerlöv E; Breese GR
J Pharmacol Exp Ther; 1984 Nov; 231(2):334-42. PubMed ID: 6491985
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic drugs and long QT syndromes: case reports.
Flugelman MY; Tal A; Pollack S; Hefez A; Weisstub EB; Gotsman MS; Lewis BS
J Clin Psychiatry; 1985 Jul; 46(7):290-1. PubMed ID: 4008455
[TBL] [Abstract][Full Text] [Related]
19. [A case report. Torsades de pointes caused by overdose of thioridazine].
Näsh O; Rydenhag A
Lakartidningen; 1993 Oct; 90(42):3677-8, 3681. PubMed ID: 8231516
[No Abstract] [Full Text] [Related]
20. Endophytic fungi as models for the stereoselective biotransformation of thioridazine.
Borges KB; Borges Wde S; Pupo MT; Bonato PS
Appl Microbiol Biotechnol; 2007 Dec; 77(3):669-74. PubMed ID: 17876580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
